Bath Savings Trust CO Bristol Myers Squibb CO Transaction History

Bath Savings Trust CO

  • $988 Million
  • Q4 2025

A detailed history of Bath Savings Trust CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bath Savings Trust CO holds 8,743 shares of BMY stock, worth $409,259. This represents 0.04% of its overall portfolio holdings.

Number of Shares
8,743
Previous 8,545 2.32%
Holding current value
$409,259
Previous $385,000 6.23%
% of portfolio
0.04%
Previous 0.04%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 12, 2026
BUY
$42.6 - $49.08 $8,434 - $9,717
198 Added 2.32%
8,743 $409,000
Q1 2025

Apr 07, 2025
SELL
$53.9 - $63.11 $35,035 - $41,021
-650 Reduced 7.07%
8,545 $521,000
Q4 2024

Jan 07, 2025
SELL
$51.92 - $59.94 $20,768 - $23,976
-400 Reduced 4.17%
9,195 $520,000
Q3 2024

Oct 07, 2024
SELL
$39.66 - $51.75 $10,311 - $13,455
-260 Reduced 2.64%
9,595 $496,000
Q2 2024

Jul 12, 2024
SELL
$40.25 - $52.99 $4,025 - $5,299
-100 Reduced 1.0%
9,855 $409,000
Q1 2024

Apr 08, 2024
SELL
$47.98 - $54.4 $18,184 - $20,617
-379 Reduced 3.67%
9,955 $539,000
Q4 2023

Jan 09, 2024
SELL
$48.48 - $57.85 $58,660 - $69,998
-1,210 Reduced 10.48%
10,334 $530,000
Q3 2023

Oct 12, 2023
SELL
$57.89 - $64.73 $98,413 - $110,041
-1,700 Reduced 12.84%
11,544 $670,000
Q2 2023

Jul 12, 2023
SELL
$63.71 - $70.74 $6,371 - $7,073
-100 Reduced 0.75%
13,244 $846,000
Q1 2023

Apr 12, 2023
SELL
$65.71 - $74.53 $13,141 - $14,906
-200 Reduced 1.48%
13,344 $924,000
Q4 2022

Jan 12, 2023
SELL
$68.48 - $81.09 $45,470 - $53,843
-664 Reduced 4.67%
13,544 $974,000
Q3 2022

Oct 05, 2022
BUY
$0.13 - $76.84 $112 - $66,697
868 Added 6.51%
14,208 $1.01 Million
Q2 2022

Jul 07, 2022
SELL
$72.62 - $79.98 $7,988 - $8,797
-110 Reduced 0.82%
13,340 $1.03 Million
Q1 2022

Apr 07, 2022
SELL
$61.48 - $73.72 $27,666 - $33,174
-450 Reduced 3.24%
13,450 $982,000
Q4 2021

Jan 03, 2022
SELL
$53.63 - $62.52 $172,259 - $200,814
-3,212 Reduced 18.77%
13,900 $867,000
Q3 2021

Oct 06, 2021
BUY
$59.17 - $69.31 $13,194 - $15,456
223 Added 1.32%
17,112 $1.01 Million
Q2 2021

Jul 07, 2021
SELL
$61.91 - $67.42 $151,369 - $164,841
-2,445 Reduced 12.65%
16,889 $1.13 Million
Q1 2021

Apr 08, 2021
SELL
$59.34 - $66.74 $86,577 - $97,373
-1,459 Reduced 7.02%
19,334 $1.22 Million
Q4 2020

Jan 13, 2021
SELL
$57.74 - $65.43 $97,291 - $110,249
-1,685 Reduced 7.5%
20,793 $1.29 Million
Q3 2020

Oct 01, 2020
SELL
$57.43 - $63.64 $14,070 - $15,591
-245 Reduced 1.08%
22,478 $1.36 Million
Q2 2020

Jul 06, 2020
SELL
$54.82 - $64.09 $54,107 - $63,256
-987 Reduced 4.16%
22,723 $1.34 Million
Q1 2020

Apr 01, 2020
SELL
$46.4 - $67.43 $20,880 - $30,343
-450 Reduced 1.86%
23,710 $1.32 Million
Q4 2019

Jan 09, 2020
BUY
$49.21 - $64.19 $362,923 - $473,401
7,375 Added 43.94%
24,160 $1.55 Million
Q3 2019

Oct 03, 2019
SELL
$42.77 - $50.71 $13,814 - $16,379
-323 Reduced 1.89%
16,785 $851,000
Q2 2019

Jul 01, 2019
BUY
$44.62 - $49.34 $25,344 - $28,025
568 Added 3.43%
17,108 $776,000
Q1 2019

Apr 02, 2019
BUY
$45.12 - $53.8 $4,512 - $5,380
100 Added 0.61%
16,540 $789,000
Q4 2018

Jan 04, 2019
SELL
$48.76 - $63.23 $11,946 - $15,491
-245 Reduced 1.47%
16,440 $854,000
Q3 2018

Oct 05, 2018
BUY
$55.19 - $62.25 $19,206 - $21,663
348 Added 2.13%
16,685 $1.04 Million
Q1 2018

Apr 03, 2018
SELL
$59.92 - $68.98 $85,386 - $98,296
-1,425 Reduced 8.02%
16,337 $1.03 Million
Q4 2017

Jan 10, 2018
BUY
$59.94 - $65.35 $12,227 - $13,331
204 Added 1.16%
17,762 $1.09 Million
Q3 2017

Oct 02, 2017
BUY
$55.23 - $63.74 $969,728 - $1.12 Million
17,558
17,558 $1.12 Million

Others Institutions Holding BMY

# of Institutions
2,692
Shares Held
1.58B
Call Options Held
28M
Put Options Held
28.4M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.5B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Bath Savings Trust CO Portfolio

Follow Bath Savings Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bath Savings Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Bath Savings Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email